Rozenfeld P, Docena G H, Añón M C, Fossati C A
Cátedra de Inmunología, Facultad de Ciencias Exactas, Facultad de Ciencias Exactas, Universidad Nacional de La Plata, La Plata, Argentina.
Clin Exp Immunol. 2002 Oct;130(1):49-58. doi: 10.1046/j.1365-2249.2002.t01-1-01935.x.
Soy-based formulas are the most employed cow's milk substitutes in the treatment of cow's milk allergy in our country. Since adverse reactions have been reported in allergic patients as a consequence of exposure to soy proteins, we have investigated the possible cross-reactivity between components from soybean and cow's milk. A cow's milk specific polyclonal antiserum and casein specific monoclonal antibodies were used in immunoblotting and competitive ELISA studies to identify a 30-kD component from soybean that cross-reacts with cow's milk caseins. Its IgE binding capacity was tested by EAST, employing sera from cow's milk allergic patients, not previously exposed to soy proteins. The 30 kD protein was isolated and partially sequenced. It is constituted by two polypeptides (A5 and B3) linked by a disulphide bond. The protein's capacity to bind to the different antibodies relies on the B3 poly-peptide. These results indicate that soy-based formula, which contains the A5-B3 glycinin molecule, could be involved in allergic reactions observed in cow's milk allergic patients exposed to soy-containing foods.
在我国,大豆配方奶粉是治疗牛奶过敏时最常用的牛奶替代品。由于有报道称过敏患者接触大豆蛋白后会出现不良反应,我们研究了大豆和牛奶成分之间可能存在的交叉反应。在免疫印迹和竞争性酶联免疫吸附测定研究中,使用了牛奶特异性多克隆抗血清和酪蛋白特异性单克隆抗体,以鉴定大豆中与牛奶酪蛋白发生交叉反应的一种30-kD成分。采用从未接触过大豆蛋白的牛奶过敏患者的血清,通过酶免疫斑点试验(EAST)检测其IgE结合能力。分离出该30 kD蛋白并进行了部分测序。它由通过二硫键连接的两种多肽(A5和B3)组成。该蛋白与不同抗体结合的能力取决于B3多肽。这些结果表明,含有A5-B3大豆球蛋白分子的大豆配方奶粉可能与接触含大豆食品的牛奶过敏患者所观察到的过敏反应有关。